Both medications represent a novel class of antibody treatments designed to neutralize the COVID-19 virus . First, sotrovimab, developed by Vir Biotechnology , demonstrated substantial efficacy against https://jesselvyq872436.aboutyoublog.com/52899519/sotrovimab-vir-7831-a-deep-investigation-into-the-protein-treatment